Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06375915
What this trial is testing

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Who this might be right for
Intrahepatic Cholangiocarcinoma
Francesco De Cobelli 33
Large-scale testing (Phase 3)WithdrawnNCT00253617
What this trial is testing

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctCholangiocarcinoma of the GallbladderUnresectable Extrahepatic Bile Duct Cancer+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02128282
What this trial is testing

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Senhwa Biosciences, Inc. 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729917
What this trial is testing

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Who this might be right for
Bile Duct CarcinomaCholangiocarcinoma
Zhejiang University 240
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06569225
What this trial is testing

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Who this might be right for
Cholangiocarcinoma Resectable
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Ended earlyNCT02955771
What this trial is testing

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Who this might be right for
Hilar Cholangiocarcinoma
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 7
Not applicableLooking for participantsNCT04504604
What this trial is testing

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Who this might be right for
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer Foundation 400
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableEnded earlyNCT01543607
What this trial is testing

Endoscopic Therapy of Malignant Bile Duct Strictures

Who this might be right for
Obstruction of Biliary TreeBiliary Tract CancerBiliary Tract Neoplasms
Massachusetts General Hospital 1
Not applicableEnrolling By InvitationNCT06076252
What this trial is testing

Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma

Who this might be right for
Ampullary CancerBile Duct CancerPancreas Cancer+1 more
Affiliated Hospital of Guangdong Medical University 150
Not applicableStudy completedNCT02592538
What this trial is testing

Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First People's Hospital of Hangzhou 66
Testing effectiveness (Phase 2)Looking for participantsNCT06501625
What this trial is testing

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Who this might be right for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Institut de Recherches Internationales Servier 52
Testing effectiveness (Phase 2)Study completedNCT02468076
What this trial is testing

Radiofrequency Ablation for Biliopancreatic Malignancy

Who this might be right for
Pancreas CancerCholangiocarcinomaObstructive Jaundice
Universitaire Ziekenhuizen KU Leuven 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269158
What this trial is testing

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsAdvanced CancerImmunotherapy
Yonsei University 160
Early research (Phase 1)Study completedNCT03438435
What this trial is testing

Fluorescence QRH-882260 Peptide Imaging in the Bile Duct

Who this might be right for
Cholangiocarcinoma
D. Kim Turgeon, MD 1
Testing effectiveness (Phase 2)Study completedNCT02631590
What this trial is testing

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Who this might be right for
Biliary CarcinomaGall Bladder CarcinomaCholangiocarcinoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableUnknownNCT05626127
What this trial is testing

MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Who this might be right for
Hilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Not applicableEnrolling By InvitationNCT05404503
What this trial is testing

Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center

Who this might be right for
Incidence of Cholangiocarcinoma on Choledochal CystsPostoperative Complications in Choledochal CystsCholedochal Cyst Monitoring
María Teresa Moreno Asencio 300
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Next Page